Disease DNA Doctors Organic Chemistry 
Drug Target Review
SEPTEMBER 28, 2023
I started my journey in chemistry – first as an undergraduate and then in my PhD programme at the University of Houston, where I focused on organic chemistry and nucleic acids chemistry. I originally wanted to be a doctor but that’s a second-tier track in France. Some of our best investors started as ‘no’s.
Elrig
APRIL 29, 2024
After graduating, Miles went on to work as a scientist on AstraZeneca’s Research and Development graduate programme, working on projects in biocatalysis, computational organic chemistry and machine learning for drug discovery.
Drug Discovery World
NOVEMBER 13, 2023
Jens Fischer, PhD, Program Manager, Large Molecule Research Therapeutic Modalities, Roche Pharma Research and Early Development (pRED), on: ‘ Bispecific and next-generation antibodies for non-oncology indications such as ophthalmologic and neurologic diseases’.
Expert insights. Personalized for you.
116 
Let's personalize your content